This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In response to Dr Ranhosky's comments, we agree that our report does not prove that dipyridamole caused the episodes of ischemia observed; however, we feel that the general medical community should be aware that dipyridamole has been demonstrated to induce myocardial ischemia in animals and man, as referenced in our report. Based on our observations, we identified a small group of patients at particular risk—notably, those with unstable angina, multivessel coronary disease, and epicardial coronary collaterals.Dr Ranhosky focuses on the incidence of myocardial infarction and death but not of ischemic episodes in "two large studies." His statement that "the incidence of severe myocardial ischemic episodes after... administration of dipyridamole is low" is unsupported. The first study has apparently not been published. The second study is completely misrepresented. Homma et al administered 300 mg of oral dipyridamole to 100 patients; fully 25% of the patients had chest pain
Keltz TN, Gitler B, Cooper JA. Dipyridamole-Induced Myocardial Ischemia-Reply. JAMA. 1987;258(2):203–204. doi:10.1001/jama.1987.03400020045019
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: